Reported changes in AMPs during chorioamnionitis, neonatal sepsis, and NEC strongly suggest their involvement in the pathogenesis of prenatal and neonatal infections and NEC, and also their potential utility as predictive and diagnostic biomarkers and as preventive and/or therapeutic agents. The gene discussed is ADSL; the disease is chorioamnionitis.